drugset

drugset / Trial / NCT05896215

OM202JP Clinical Study of KNP2002

NCT05896215 ↗

Phase 2 Completed 159 enrolled KinoPharma Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to evaluate safety and efficacy of KNP2002 in patients with common warts aged 15 to 50 years old.

Timeline

Start: 2023-06-12
Primary completion: 2024-07-27
Completion: 2024-07-27

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	KNP2002	Unknown	—	Topical

Indications